Literature DB >> 2398251

Effect of lactitol and lactulose administration on the fecal flora in cirrhotic patients.

O Riggio1, M Varriale, G P Testore, R Di Rosa, E Di Rosa, M Merli, A Romiti, C Candiani, L Capocaccia.   

Abstract

We compared the effect of lactulose or lactitol on the fecal flora of 21 cirrhotic patients without hepatic encephalopathy. All were treated with an individualized disaccharide dose to achieve and maintain two semiliquid bowel movements per day. Stool pH and fecal flora were determined before and 10 days after stabilizing the cathartic effect. Increased counts of lactobacilli were obtained with both treatments. This increase, which was related to the decreased stool pH, was more constant with lactulose. In addition, lactitol decreased certain proteolytic bacteria such as enterococci and enterobacteria. Both total aerobic and anaerobic bacterial counts showed little quantitative variations with either treatment.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2398251     DOI: 10.1097/00004836-199008000-00016

Source DB:  PubMed          Journal:  J Clin Gastroenterol        ISSN: 0192-0790            Impact factor:   3.062


  29 in total

Review 1.  Acute variceal bleeding: risk stratification and management (including TIPS).

Authors:  Virginia Hernández-Gea; Claudia Berbel; Anna Baiges; Juan C García-Pagán
Journal:  Hepatol Int       Date:  2017-06-20       Impact factor: 6.047

Review 2.  Gut microbiota: its role in hepatic encephalopathy.

Authors:  Rahul Rai; Vivek A Saraswat; Radha K Dhiman
Journal:  J Clin Exp Hepatol       Date:  2014-12-16

Review 3.  Gut-liver axis in liver cirrhosis: How to manage leaky gut and endotoxemia.

Authors:  Hiroshi Fukui
Journal:  World J Hepatol       Date:  2015-03-27

4.  Linkage of gut microbiome with cognition in hepatic encephalopathy.

Authors:  Jasmohan S Bajaj; Jason M Ridlon; Phillip B Hylemon; Leroy R Thacker; Douglas M Heuman; Sean Smith; Masoumeh Sikaroodi; Patrick M Gillevet
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2011-09-22       Impact factor: 4.052

Review 5.  The role of microbiota in hepatic encephalopathy.

Authors:  Jasmohan S Bajaj
Journal:  Gut Microbes       Date:  2014-04-01

Review 6.  Pathophysiology, diagnosis, and management of hepatic encephalopathy.

Authors:  Christopher Sheasgreen; Lucy Lu; Ameen Patel
Journal:  Inflammopharmacology       Date:  2014-10-10       Impact factor: 4.473

Review 7.  Altered Microbiome in Patients With Cirrhosis and Complications.

Authors:  Chathur Acharya; Jasmohan S Bajaj
Journal:  Clin Gastroenterol Hepatol       Date:  2018-08-09       Impact factor: 11.382

Review 8.  Lactulose, disaccharides and colonic flora. Clinical consequences.

Authors:  M R Clausen; P B Mortensen
Journal:  Drugs       Date:  1997-06       Impact factor: 9.546

Review 9.  Microbiota and the gut-liver axis: bacterial translocation, inflammation and infection in cirrhosis.

Authors:  Valerio Giannelli; Vincenza Di Gregorio; Valerio Iebba; Michela Giusto; Serena Schippa; Manuela Merli; Ulrich Thalheimer
Journal:  World J Gastroenterol       Date:  2014-12-07       Impact factor: 5.742

10.  Polydextrose, lactitol, and fructo-oligosaccharide fermentation by colonic bacteria in a three-stage continuous culture system.

Authors:  Hollie M Probert; Juha H A Apajalahti; Nina Rautonen; Julian Stowell; Glenn R Gibson
Journal:  Appl Environ Microbiol       Date:  2004-08       Impact factor: 4.792

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.